BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 2508565)

  • 1. [FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
    Hayakawa M; Morise K; Oka Y; Suga S; Suzuki T; Kaneshiro K; Tsunekawa H; Hayashi N; Umemura K; Yoshida H
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3073-9. PubMed ID: 2847659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
    Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
    Ono T; Komatsu M; Hoshino T; Ishii T; Fujii K; Ohshima S; Mikami K; Masamune O; Fukuda T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1709-12. PubMed ID: 8886050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
    Sawa T; Kinoshita K; Takekawa S; Ohyama S; Hasegawa K; Fujimura T; Ueda N; Watanabe T; Kato M; Miyata T
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2381-6. PubMed ID: 2260875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
    Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced gastric cancer (Borrmann's type 2) that disappeared following short-term preoperative chemotherapy with UFT].
    Uesugi H; Azuumi Y; Saigenji K; Okabe H; Mieno H; Motoori T
    Gan No Rinsho; 1989 Jul; 35(8):963-9. PubMed ID: 2501536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of scirrhous gastric cancer].
    Wakui A
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2398-406. PubMed ID: 7944483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Issues of adjuvant chemotherapy in gastric cancer: its clinical significance].
    Nakajima T
    Gan To Kagaku Ryoho; 1991 May; 18(6):952-7. PubMed ID: 2029198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in oral chemotherapy options for gastric carcinoma.
    Ajani JA; Takiuchi H
    Drugs; 1999; 58 Suppl 3():85-90. PubMed ID: 10711846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Process of making a protocol for advanced gastric cancer chemotherapy--using 5'-DFUR+CDDP as an example].
    Kurihara M
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2447-53. PubMed ID: 8279840
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.